Results

Gene vaccine for Alzheimer's disease shows promising results

UT Southwestern Medical Center at Dallasresearchers have found a way of stimulating the immune systems of miceto fight against amyloid proteins that cause the devastating plaquesthat are characteristic of Alzheimer's disease.For years scientists have examined the possibility of using aprotein-based vaccine to slow the progression of the disease in itsearly stages. UT Southwestern researcher...

Roche clinical trial registry and results database launched

Within only three months after deciding to create an electronic database, Roche is launching a public clinical trial registry and results database using an independent host, CenterWatch. On www.roche-trials.com information on Roche’s clinical trials can be accessed by anyone, anywhere, with no password restrictions. This site is designed to give patients and healthcare providers ready access to i...

Diabetic nerve therapy shows 'striking' results

Research into a new treatment for nerve damage caused by diabetes could bring relief to millions of diabetic patients, say experts. The treatment might also reduce the number of amputations of toes and feet if early effects on nerve protection and regeneration are borne out long-term. Nerve disease in diabetes is the major cause of non-traumatic lower limb amputations in Europe and North...

Neurologix announces positive results of gene therapy clinical trial in Parkinson's disease

Investigators report safety findings and statistically significant improvements in clinical measures of movement, PET Scans at 19th Annual Symposia on the Etiology, Pathogenesis and Treatment of Parkinson's Disease and Other Movement DisordersNeurologix's Phase I trial showed positive interim results in patients with Parkinson's disease. One year following treatment, patients exhibited a statist...

Results of world's first gene therapy trial for arthritis show approach safe, feasible

Gene therapy for arthritis and other non-terminal, debilitating conditions and diseases is both feasible and safe, report researchers who conducted the world's first such test on the approach in patients with advanced rheumatoid arthritis. The results, published in this week's online edition of the Proceedings of the National Academy of Sciences (PNAS), indicate that introducing a new gene has th...

More>>

Results at Biology Products

No data found

Search Results biology products at Google

Search Results biology products at Yahoo

Search Results biology products at Msn

Results at Biology Technology

Effects of Thermal Cycler Well-To-Well Temperature Uniformity on PCR Results

Michelle Cayouette Jane Moores Jason Capodanno Michael Rahilly Stratagene produces consistent PCR results in every well. The RoboCycler systems uniquedesign uses thermal blo...

HotMasterAn innovative Hot Start/Cold Stop technology for better PCR* results

George Halley, Eppendorf 5 Prime, Inc., Boulder, CO, USA Vincent Prezioso, Brinkmann Instruments, BioSytems Application Lab, Westbury, NY Hot Start DNA polymerases have become very popular because of their conven...

Achieving Reliable Protein Quantitation Results Using ICAT Reagents, MALDITOF Mass Spectrometry, and Advanced Data Interpretation Tool

A challenge of quantitative analysis of complex protein mixtures using isotope coded affinity tags is to correctly identify and obtain accurate quantitative information for ICAT reagent pairs on a spectrum generated by mass spectrometry. Because MALDI-TOF mass spectrometry can easily generate peptide mass fingerprint profiles and relative quan...

How Best Buy said bye to burnout, hello to results

It's about time. A large corporation with a strong workaholic and face-time culture and without a vested interest in flexible working...

Economic survey reveals better 2006 results

and the <a href=...

More>>

Results at Medicine News

Experimental treatment for Ebola Virus Shows promising results in mice

Scientists at the Center for Disease Control and Prevention (CDC) in Atlanta, Georgia, have said that an experimental treatment for the deadly Ebola virus has shown promising results in mice. In the study, researchers led by Dr. Manish Gupta took antibodies from the immune systems of mice that had survived infection with the deadly Ebola virus and injected them into other Ebola-free mice...

Hormone Deficiency Results In Miscarriage

A deficiency in a protective hormone may be behind some early miscarriages, preliminary research suggests. The hormone, called corticotropin-releasing hormone (CRH), is normally released by the mother and the embryo soon after it implants itself in the womb. Without it, the embryo may be left vulnerable to attack from the mother's immune system.// CRH triggers the production of a prote...

Gleevec gets hopeful results

The Food and Drug Administration approved the drug, Gleevec, for the treatment of chronic myelogenous leukemia, a form of cancer that affects about 4,500 people in the USA each year. A study supports Gleevec's image as a potential cure for this kind of cancer, which, although cases are rare, can be deadly. // A new study adds to the evidence suggesting that a heavily publicized drug tr...

Insurers Want Breast Cancer Test Results

Insurers in Britain are planning to impose higher premiums on women who have not tested themselves for breast cancer. Insurers have approached government regulators in this regard and are asking that women test themselves for the BRCA1 and BRCA2 genetic mutations,// which play a huge role in the development of breast and ovarian cancers. Currently, the insurance industry cannot ask for...

Revealing Study Results May Do More Harm Than Good

There has been clamor recently to disclose the results of study findings with participants after the completion of the study. However, a commentary published in the April 1, 2006 issue of CANCER,// a peer-reviewed journal of the American Cancer Society, says that such disclosures may actually do more harm than good as they cause unnecessary psychological stress to patients. Maurie Markm...

More>>

Results at Medicine Products

PatientKeeper's Clinical Results

Description:Designed to inform decision making, PatientKeeper's Clinical Results delivers complete patient data on demand. Clinicians can rely on immediate access to lab results, medication profiles, microbiology and radiology reports, allergy profiles, and clinical notes such as consultation and daily progress....
Company:PatientKeeper

Results at Medicine Technology

Point of Care Cardiac Analyzers Yield Rapid Cardiac Marker Results

Clinical guidelines from the disciplines of cardiology and laboratory and emergency medicine have all emphasized the importance of cardiac markers in diagnosing or ruling out acute myocardial infarction. The measurement of cardiac troponins is especially useful in the large fraction of patients presenting with acute coronary syndrome (ACS) who have...

Diagnosing Diabetes: Immediate HbA1c Results Improve Glycemic Control

According to the American Diabetes Association, the total annual economic cost of diabetes in 2002 was estimated to be $132 billion, or one out of every 10 health care dollars spent in the United States. A chronic disease with no cure, diabetes is a group of diseases (including Type 1, Type 2, and gestational) marked by...

Cell Therapeutics, Inc. Management to Discuss Today's Announcement of Interim Pixantrone Study Results

SEATTLE, July 11, 2007 /PRNewswire-FirstCall/ -- On Wednesday,July 11, 2007, at 1:30 p.m. Pacific/4:30 p.m. Eastern/10:30 p.m.Central European Time members of Cell Therapeutics, Inc.'s (CTI)management team will host a conference call to discuss today'sannouncement of the interim results of its phase II/III RAPID trialcomparing CHOP-R to CPOP-R, in which pixantrone is substituted fordoxor...

Sygnis Pharma AG announces date for presentation of clinical results

HEIDELBERG, Germany, 11 July 2007 – On 23 July SYGNIS PharmaAG will present the results of the clinical phase IIa study forAX200 (AXIS-study). AX200, a compound for the treatment of stroke, is the mostadvanced drug candidate in SYGNIS’ product pipeline. Theprimary aim of the study is to show safety and tolerability ofAX200 in acute stroke patients. The results of the AXIS-stud...

Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis

RIDGEFIELD, Conn., July 11, 2007 /PRNewswire/ -- Phase 3 resultsfrom the RE-NOVATE(TM) trial demonstrated that oral dabigatranetexilate once daily, administered for an average of 33 days, wasnon-inferior to enoxaparin, also administered for an average of 33days, in preventing venous thromboembolism (VTE) and all-causemortality after total hip replacement surgery. In this trial, therate o...

More>>